Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#STD Diagnostics Market Size Outlook: How Quickly Will Revenue Expand Through 2030?#_x000D_
The std diagnostics market size has shown rapid expansion in recent years. This market is set to increase from $10.77 billion in 2025 to $11.91 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. Historically, this growth can be attributed to factors such as the increasing prevalence of sexually transmitted infections, the expansion of diagnostic laboratory infrastructure, the development of public health screening programs, rising awareness of sexual health, and the availability of advanced nucleic acid testing._x000D_
_x000D_
The std diagnostics market size is projected to experience swift expansion over the coming years. By 2030, this market is anticipated to reach $17.52 billion, exhibiting a compound annual growth rate (CAGR) of 10.1%. The expansion during the forecast period is fueled by several factors, including a heightened demand for rapid diagnostics, the growing acceptance of home-based testing kits, broader penetration of molecular diagnostics, increased investments in public health surveillance, and a stronger emphasis on confidential and accessible testing services. Key trends for the forecast duration involve a greater uptake of rapid and point-of-care std tests, the expanding utilization of molecular diagnostic technologies, increasing incorporation of automated laboratory systems, the proliferation of at-home std testing solutions, and an intensified focus on early and precise disease detection._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#STD Diagnostics Market Growth Drivers: What’s Behind The Acceleration?#_x000D_
The increasing occurrence of sexually transmitted diseases is anticipated to propel the expansion of the STD diagnostics market in the future. Sexually transmitted diseases (STDs) are infections spread via sexual contact, necessitating professional medical diagnosis and intervention. This rise in STD prevalence stems from heightened sexual activity and evolving social norms among younger demographics, where diminished stigma regarding sexual health and enhanced mobility foster broader sexual networks and accelerate transmission rates. The expanding prevalence of STDs directly fuels a greater need for diagnostic testing services and products, given that healthcare professionals depend on precise laboratory tests, screening kits, and detection methods to identify infections and curb their spread. As an illustration, in September 2025, the Centers for Disease Control and Prevention, a US-based government administration, reported that congenital syphilis had escalated for the twelfth successive year, totaling nearly 4,000 reported cases in 2024. Consequently, the increasing incidence of STDs is a key factor propelling the expansion of the STD diagnostics market._x000D_
_x000D_
#STD Diagnostics Market Breakdown By Product Type And Application#_x000D_
The std diagnostics market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Chlamydia Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus Testing, Human Papilloma Virus Testing, Human Immunodeficiency Virus Testing, Chancroid Testing_x000D_
2) By Location Of Testing: Laboratory Testing, Point Of Care (PoC) Testing_x000D_
3) By End-User: Hospitals And Clinics, Diagnostic Centers, Homecare_x000D_
_x000D_
Subsegments:_x000D_
1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT), Antigen Tests _x000D_
2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests, Treponemal Tests _x000D_
3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT), Culture Tests _x000D_
4) By Herpes Simplex Virus Testing: PCR Tests, Serological Tests _x000D_
5) By Human Papilloma Virus Testing: HPV DNA Tests, HPV RNA Tests _x000D_
6) By Human Immunodeficiency Virus Testing: Antibody Tests, Antigen Or Antibody Tests, Nucleic Acid Tests (NAT) _x000D_
7) By Chancroid Testing: Culture Tests, Nucleic Acid Tests_x000D_
_x000D_
#STD Diagnostics Market Trends: What’s Defining The Industry’s Next Phase?#_x000D_
Leading companies in the STD diagnostics market are dedicated to developing innovative products, such as real-time PCR kits, to address outstanding medical needs and enhance diagnostic capabilities. A real-time PCR kit comprises a set of reagents utilized for performing real-time polymerase chain reaction (qPCR), which is a highly sensitive and widely adopted technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, launched the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, which are designed for the identification of Mycoplasma hominis and Treponema pallidum. Moreover, these products exhibit high sensitivity and specificity, ease of use, rapid turnaround time, and the capability to detect several pathogens in a single test._x000D_
_x000D_
#STD Diagnostics Market Key Players Shaping Industry Direction#_x000D_
Major companies operating in the std diagnostics market are Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMérieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy _x000D_
_x000D_
#View The Full STD Diagnostics Market Report:#_x000D_
_x000D_
#STD Diagnostics Market Regional Analysis: Which Geography Leads On Revenue?#_x000D_
North America was the largest region in the STD diagnostics market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.